The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLSN.L Regulatory News (CLSN)

  • There is currently no data for CLSN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

25 Mar 2020 07:00

RNS Number : 4694H
Calisen plc
25 March 2020
 

25 March 2020

 

 

COVID-19 Update

 

 

Calisen plc ("Calisen" and together with its subsidiaries the "Group") has taken the decision to temporarily suspend all non-essential installations and field services. This follows recent direction from the UK Government and consultation with its customers who have also taken similar decisions in respect of their own installation activities.

 

The Group's priority is the safety and wellbeing of its staff, customers and consumers. Calisen's Lowri Beck subsidiary has therefore closed all its offices and warehouses with the exception of facilities used by a small group of engineers who remain on standby to respond to emergency call-outs.

 

Since there will now be a reduction in installations, Calisen is withdrawing guidance for an average of 100,000 meter installations per month in 2020. Given the uncertainty over the duration of the COVID-19 outbreak, it is not possible to give revised guidance for 2020 installations at this stage. 

 

Cash flow and balance sheet remain strong

 

The reduction in the number of meter installations for a period of time will reduce the capital expenditure requirement. Additionally, reduced smart meter installations are expected to result in our traditional meters remaining on the wall and generating revenue for longer. The Group has a large existing portfolio of 8.6 million revenue generating meters (at 31 December 2019). This existing portfolio of meters produces the great majority of existing and recurring revenue, EBITDA and cashflow for the Group, which Calisen does not expect to be impacted by the measures currently proposed to tackle COVID-19. With existing meters continuing to generate cash and lower levels of capital expenditure, the Group's net cashflow will increase during this period.

 

At IPO, Calisen raised £300m of additional funds (prior to fees) of which the majority was used to de-lever the business. The Group, as at the end of February, had cash balances available of £78.9 million and committed undrawn funding facilities in place of £984.7 million, including an undrawn 5-year £240 million revolving credit facility. These facilities combined with internally generated cashflow mean the Group has sufficient funding to meet its pipeline of metering opportunities as disclosed at the time of the listing. No meter funding facility renewals fall due before October 2022 with most debt structured as long-term amortising facilities.

 

Current trading and outlook

 

Trading for the year-ended 31 December 2019 and for the period ended February 2020 has been in line with expectations. The Group intends to provide more detailed information regarding 2019 performance in its full year results on 21 April 2020.

 

Calisen currently believes the impact from COVID-19 will not be material to its longer-term plans for growth in the metering portfolio to the end of 2024.

 

Commenting, Calisen CEO Bert Pijls said:

 

"As COVID-19 continues to have a profound impact on lives across the UK, we believe it appropriate to take action to minimise its impact and safeguard the health and well-being of our employees, customers and consumers by temporarily suspending non-essential installations and field services.

 

"Since our IPO in February, Calisen's installed meter portfolio has continued to generate steady and resilient cash flows underpinned by our strong balance sheet. I am confident that the combination of our solid business model and financial strength will see the Group deliver growth as expected in the longer term."

 

 

Media enquiries

 

Finsbury (public relations adviser to Calisen)

Dorothy Burwell / Harry Worthington

+44 7733 294 930 / +44 7818 526 556

Calisen-LON@finsbury.com 

 

Investor and analyst enquiries

 

Calisen investor relations:

Adam Key, Investor Relations DirectorTel: +44 161 220 1900 / Mob: +44 7572 231453adam.key@calisen.com

 

This announcement includes forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond the Group's control and all of which are based on the Directors' current beliefs and expectations about future events. Forward-looking statements are sometimes identified by the use of forward-looking terminology such as "guidance", "believe", "expects", "may", "will", "could", "should", "shall", "risk", "intends", "estimates", "aims", "plans", "predicts", "continues", "assumes", "positioned", "targets" or "anticipates" or the negative thereof, other variations thereon or comparable terminology. These forward-looking statements include all matters that are not historical facts and include statements regarding the intentions, beliefs or current expectations of the Directors or the Group concerning, among other things, the results of operations, financial condition, prospects, growth, strategies, and dividend policy of the Group and the industry in which it operates. No assurance can be given that such future results will be achieved; actual events or results may differ materially as a result of risks and uncertainties facing the Group. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed, or implied in such forward-looking statements. Such forward-looking statements contained in this announcement speak only as of the date of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFZGZFMDMGGZZ
Date   Source Headline
16th Sep 20204:36 pmRNSPrice Monitoring Extension
16th Sep 202012:02 pmRNSPrice Monitoring Extension
10th Sep 20204:35 pmRNSPrice Monitoring Extension
27th Aug 202012:07 pmRNSSecond Price Monitoring Extn
27th Aug 202012:02 pmRNSPrice Monitoring Extension
24th Aug 202012:07 pmRNSSecond Price Monitoring Extn
24th Aug 202012:02 pmRNSPrice Monitoring Extension
21st Aug 202012:07 pmRNSSecond Price Monitoring Extn
21st Aug 202012:02 pmRNSPrice Monitoring Extension
13th Aug 202012:07 pmRNSSecond Price Monitoring Extn
13th Aug 202012:02 pmRNSPrice Monitoring Extension
4th Aug 20204:41 pmRNSSecond Price Monitoring Extn
4th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSCalisen Half Year Results
31st Jul 202012:07 pmRNSSecond Price Monitoring Extn
31st Jul 202012:02 pmRNSPrice Monitoring Extension
31st Jul 20207:00 amRNSBoard changes
30th Jul 202012:07 pmRNSSecond Price Monitoring Extn
30th Jul 202012:02 pmRNSPrice Monitoring Extension
20th Jul 202012:07 pmRNSSecond Price Monitoring Extn
20th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 202011:00 amRNSCalisen announces c.£1.1 billion refinancing
29th Jun 20207:00 amRNSResumption of smart meter installations
26th Jun 202011:00 amRNSDirector/PDMR Shareholding
24th Jun 202012:07 pmRNSSecond Price Monitoring Extn
24th Jun 202012:02 pmRNSPrice Monitoring Extension
23rd Jun 202012:02 pmRNSPrice Monitoring Extension
22nd Jun 20203:00 pmRNSReduction of capital
22nd Jun 202012:07 pmRNSSecond Price Monitoring Extn
22nd Jun 202012:02 pmRNSPrice Monitoring Extension
18th Jun 20207:00 amRNSOperational review of Lowri Beck
4th Jun 20203:00 pmRNSCalisen plc Results of Annual General Meeting
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20203:00 pmRNSNotice of AGM
1st May 20203:00 pmRNSDirector/PDMR Shareholding
21st Apr 20207:00 amRNSCalisen plc Full Year Results
17th Apr 20207:00 amRNSAppointment of Joint Corporate Brokers
9th Apr 202012:07 pmRNSSecond Price Monitoring Extn
9th Apr 202012:02 pmRNSPrice Monitoring Extension
3rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
3rd Apr 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20204:41 pmRNSSecond Price Monitoring Extn
27th Mar 20204:37 pmRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSCOVID-19 Update
13th Mar 20207:00 amRNSHolding(s) in Company
11th Mar 20204:00 pmRNSDirector/PDMR Shareholding
6th Mar 20206:25 pmRNSExercise of Over-Allotment Option
6th Mar 20206:19 pmRNSEnd of Stabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.